TNF and leukemia: While the safety experience with TNF inhibitors in adult RA patients may provide some insights into the pediatric population, it is important to note that RA and JIA are different diseases and the association of the adult RA disease state with increased risk for lymphoma or leukemia may or may not translate into an increased risk in the JIA population.